| Mr James Rob Aronow, SLP | |
|
414 Superior St, Sandpoint, ID 83864-1619 | |
| (208) 245-4576 | |
| (208) 245-2138 |
| Full Name | Mr James Rob Aronow |
|---|---|
| Gender | Male |
| Speciality | Speech-language Pathologist |
| Location | 414 Superior St, Sandpoint, Idaho |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003147448 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SLP 1693 (Idaho) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr James Rob Aronow, SLP 414 Superior St, Sandpoint, ID 83864-1619 Ph: (208) 245-4576 | Mr James Rob Aronow, SLP 414 Superior St, Sandpoint, ID 83864-1619 Ph: (208) 245-4576 |
News Archive
Millennium: The Takeda Oncology Company today announced that the U.S. Food and Drug Administration (FDA) has granted priority review to the Company's supplemental new drug application (sNDA) for VELCADE. The sNDA contains long-term overall survival (OS) data from the landmark VISTA trial examining the use of VELCADE based therapy in patients with previously untreated multiple myeloma (MM).
A new analysis may help doctors identify breast cancer patients who will benefit from treatment with the immune suppressant drug everolimus, say French researchers at the 4th IMPAKT Breast Cancer Conference in Brussels, Belgium.
In a study of 10 large health systems, Dartmouth investigators Carrie H. Colla, PhD, Philip P. Goodney, MD, MS, and Ellen R. Meara, PhD, and others from Dartmouth and the University of Michigan found that implementation of pilot accountable care organizations (ACOs) did not limit spending on discretionary or non-discretionary cardiovascular treatment for patients.
Novo Nordisk today announced that formal feedback from the United States Food and Drug Administration (FDA) regarding liraglutide, a once-daily human GLP-1 analogue, is expected within weeks.
The general public are worryingly ignorant about the symptoms and risk factors that contribute to serious medical conditions such as stroke and HIV/AIDS, according to a study published in the online open access journal BMC Medicine.
› Verified 4 days ago
Tina L Sleyster, MCSD CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 724 Pine St, Sandpoint, ID 83864 Phone: 208-263-1843 | |
Deborah K Faude, MA CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 724 Pine St, Sandpoint, ID 83864 Phone: 208-263-1843 | |
Mr. Charles E Kees, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 220 S Division Ave, Sandpoint, ID 83864 Phone: 208-265-4514 Fax: 208-263-3789 | |
North Idaho Speech Language Associates Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 724 Pine St, Sandpoint, ID 83864 Phone: 208-263-1843 Fax: 208-263-1843 | |
Ms. Jean Gerth, CCC-SP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 551 E Sunnyside Rd, Sandpoint, ID 83864 Phone: 208-290-1349 | |
Alyssa Y Jacobson, MS Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 724 Pine St, Sandpoint, ID 83864 Phone: 208-263-1843 |